Patient Square Capital LP Increases Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN)
MarketBeat
Patient Square Capital LP grew its position in Enliven Therapeutics, Inc. (NASDAQ:ELVN - Free Report) by 147.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 224,038 shares of the company's stock after buying an additional 133,466 shares during the period. Enl
NASDAQ:ELVN